Conference Proceedings

An International Multicenter Retrospective Comparison of Induction Chemoimmunotherapy Regimens on Outcomes in Patients with Transplant-Eligible Mantle Cell Lymphoma

Zi Yun Ng, Mark Bishton, David Ritchie, Robert Campbell, Michael P Gilbertson, Kate Hill, Sumita Ratnasingam, Anthony P Schwarer, Kate Manos, Sophie Shorten, Melissa Liet Hing Ng, Niles Elizabeth Nelson, Liu Xin, Sanjay De Mel, Tenny Sunny, Duncan Purtill, Michelle Poon, Anna M Johnston, Tara Cochrane, Hui-Peng Lee Show all

BLOOD | AMER SOC HEMATOLOGY | Published : 2017


Funding Acknowledgements

Roche: Other: Travel Sponsorship. Ritchie: Amgen Inc.: Honoraria. Schwarer: Novartis: Honoraria; Bristol-Myers Squibb: Honoraria; Celgene: Honoraria; Roche: Honoraria; Amgen: Honoraria; Specialised Therapeutics: Honoraria. Tam: Janssen Cilag: Honoraria, Research Funding; Abbvie: Honoraria, Research Funding; Roche: Honoraria, Research Funding. Opat: Roche: Consultancy, Honoraria, Research Funding, Speakers Bureau; Gilead: Consultancy, Honoraria, Research Funding, Speakers Bureau; Janssen: Consultancy, Honoraria, Speakers Bureau; Beigene: Research Funding; Mundipharma: Consultancy; Amgen: Research Funding. Hawkes: Roche: Other: Travel expenses; Bristol-Myers Squibb: Research Funding; Roche: Other: Travel expenses, Research Funding; Celgene: Research Funding; Janssen: Membership on an entity's Board of Directors or advisory committees, Research Funding; Takeda: Other: Travel expenses; Merck Serono: Research Funding; Merck Sharpe Dohme: Research Funding.